| 2026-02-12 | -69.4% | news | Investing.com | STRATA Skin Sciences stock plunges after Nasdaq delisting notice - Investing.com |
| 2026-02-11 | -67.0% | legal | GlobeNewswire | Laseroptek America Files Counterclaims Alleging Anticompetitive and Unfair Business Practices in Ongoing Litigation with Strata Skin Sciences |
| 2026-02-11 | -67.0% | legal | SEC EDGAR | SSKN 8-K: 3.01 and 8.01 (SEC Filing) |
| 2026-02-11 | -67.0% | news | TradingView | STRATA Skin Sciences Received Notice of Delisting - TradingView |
| 2026-02-11 | -67.0% | news | Stock Titan | Strata Skin Sciences (NASDAQ: SSKN) plans Nasdaq exit and goes dark - Stock Titan |
| 2026-02-18 | -47.1% | news | Zacks | SSKN Stock Falls Despite Meta-Analysis Backs Excimer Laser's Efficacy |
| 2026-02-18 | -47.1% | news | GlobeNewswire | Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser |
| 2026-02-18 | -47.1% | news | Zacks Investment Research | Should I buy Strata Skin Sciences (SSKN) - Zacks Investment Research |
| 2026-02-18 | -47.1% | news | Yahoo Finance | SSKN Stock Falls Despite Meta-Analysis Backs Excimer Laser's Efficacy - Yahoo Finance |
| 2026-02-18 | -47.1% | news | Stock Titan | New Johns Hopkins laser targets stubborn psoriasis and vitiligo - Stock Titan |
| 2026-02-17 | -46.4% | news | GlobeNewswire | STRATA Skin Sciences Highlights Meta-Analysis Confirming Clinical Efficacy of 308 nm Excimer Laser for Plaque Psoriasis |
| 2026-02-17 | -46.4% | news | Stock Titan | Psoriasis meta-analysis finds up to 85% severity drop with 308 nm laser - Stock Titan |
| 2026-02-17 | -46.4% | news | GlobeNewswire | STRATA Skin Sciences Highlights Meta-Analysis Confirming - GlobeNewswire |
| 2025-09-03 | -41.3% | news | Seeking Alpha | STRATA Skin Sciences announces $2.42M registered direct offering; shares down |
| 2025-09-03 | -41.3% | legal | SEC EDGAR | SSKN 8-K: 1.01, 7.01 (SEC Filing) |
| 2025-09-03 | -41.3% | news | Yahoo Finance | STRATA Skin Sciences Announces Pricing of $2.42 Million Registered Direct Offering of Common Stock Priced At-Market Under Nasdaq Rules - Yahoo Finance |
| 2023-11-15 | +40.3% | legal | SEC EDGAR | SSKN 8-K: 5.02 (SEC Filing) |
| 2023-11-15 | +40.3% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-10-14 | +29.5% | news | RagingBull | SSKN Stock Explodes Higher on Exciting Breakthrough in Rare Skin Cancer Treatment - RagingBull |
| 2025-10-14 | +29.5% | news | Investing.com | Nasdaq grants Strata Skin Sciences extension to meet equity listing rule - Investing.com |
| 2023-08-09 | -25.8% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-01-03 | +20.4% | news | Seeking Alpha | STRATA Skin granted extension by Nasdaq to regain compliance with minimum bid requirement |
| 2024-01-03 | +20.4% | news | GlobeNewswire | STRATA Skin Granted Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement - GlobeNewswire |
| 2024-04-26 | -20.2% | news | Seeking Alpha | STRATA Skin Sciences announces 1-for-10 reverse stock split |
| 2024-03-27 | -18.2% | earnings | Seeking Alpha | STRATA Skin Sciences GAAP EPS of -$0.11 misses by $0.09, revenue of $8.7M misses by $1.31M |
| 2024-03-27 | -18.2% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-11-13 | -17.4% | earnings | Seeking Alpha | STRATA Skin Sciences GAAP EPS of -$0.36 beats by $0.17, revenue of $6.93M misses by $0.79M |
| 2025-11-13 | -17.4% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-08-26 | +13.5% | news | Seeking Alpha | STRATA files complaint against three companies, citing unfair competition in sales of laser devices |
| 2023-07-06 | +10.9% | legal | SEC EDGAR | SSKN 8-K: 1.01, 2.03 (SEC Filing) |
| 2024-08-15 | -10.9% | earnings | Seeking Alpha | STRATA Skin Sciences, Inc. (SSKN) Q2 2024 Earnings Call Transcript |
| 2023-10-30 | -9.4% | legal | SEC EDGAR | SSKN 8-K: 5.02, 5.07 (SEC Filing) |
| 2024-03-28 | -8.9% | earnings | Seeking Alpha | STRATA Skin Sciences, Inc. (SSKN) Q4 2023 Earnings Call Transcript |
| 2024-05-14 | +8.8% | earnings | Seeking Alpha | STRATA Skin Sciences Q1 2024 Earnings Preview |
| 2023-03-31 | -8.8% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-06-30 | +8.3% | legal | SEC EDGAR | SSKN 8-K: 3.01, 7.01, 8.01 (SEC Filing) |
| 2024-11-14 | -8.2% | earnings | Seeking Alpha | STRATA Skin Sciences, Inc. (SSKN) Q3 2024 Earnings Call Transcript |
| 2024-07-22 | -7.2% | news | Seeking Alpha | STRATA Skin Sciences gets approval for its excimer laser device in Japan |
| 2024-05-16 | -7.1% | earnings | Seeking Alpha | STRATA Skin Sciences, Inc. (SSKN) Q1 2024 Earnings Call Transcript |
| 2024-04-09 | +7.0% | expansion | Seeking Alpha | STRATA Skin Sciences renews distribution agreements in China and Japan |
| 2024-11-22 | -5.8% | news | Seeking Alpha | STRATA Skin Sciences files for mixed shelf offering |
| 2025-10-16 | -5.4% | legal | SEC EDGAR | SSKN 8-K: 8.01 and (SEC Filing) |
| 2025-03-27 | +5.3% | earnings | Seeking Alpha | STRATA Skin Sciences GAAP EPS of -$1.18 misses by $0.88, revenue of $9.6M beats by $0.62M |
| 2025-03-27 | +5.3% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01 (SEC Filing) |
| 2021-11-10 | -5.3% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-03-21 | -5.0% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01 (SEC Filing) |
| 2021-08-20 | +4.9% | legal | SEC EDGAR | SSKN 8-K: 8.01 (SEC Filing) |
| 2021-08-17 | +4.7% | legal | SEC EDGAR | SSKN 8-K: 1.01 and (SEC Filing) |
| 2023-04-12 | -4.7% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-12-29 | -4.6% | expansion | Seeking Alpha | STRATA Skin Sciences announces expansion of distribution agreement with Kosmo Meditech |
| 2023-12-29 | -4.6% | legal | SEC EDGAR | SSKN 8-K: 7.01, 8.01 (SEC Filing) |
| 2025-05-14 | +4.5% | earnings | Seeking Alpha | Strata Skin Sciences outlines multi-quarter Elevate 360 expansion as recurring revenue per device rises for fourth consecutive quarter |
| 2025-05-14 | +4.5% | earnings | Seeking Alpha | STRATA Skin Sciences, Inc. (SSKN) Q1 2025 Earnings Call Transcript |
| 2025-05-14 | +4.5% | earnings | Seeking Alpha | STRATA Skin Sciences GAAP EPS of -$0.58 misses by $0.06, revenue of $6.8M misses by $0.48M |
| 2025-05-14 | +4.5% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-07-11 | +4.4% | earnings | Seeking Alpha | STRATA Skin Sciences reports Q2 results |
| 2024-07-11 | +4.4% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01, 8.01 (SEC Filing) |
| 2021-08-16 | +4.2% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-12-14 | +4.2% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Strata Skin Sciences (SSKN) - Zacks Investment Research |
| 2023-02-01 | +4.0% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01 (SEC Filing) |
| 2021-12-09 | -3.6% | legal | SEC EDGAR | SSKN 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-11-14 | -3.0% | news | Seeking Alpha | Strata Skin Sciences outlines threefold market expansion opportunity as CPT code revisions approach 2027 |
| 2025-11-14 | -3.0% | earnings | Seeking Alpha | STRATA Skin Sciences, Inc. (SSKN) Q3 2025 Earnings Call Transcript |
| 2025-08-14 | -3.0% | news | Seeking Alpha | Strata Skin Sciences signals threefold TAM expansion as CPT code changes unlock 30M patient market |
| 2025-08-14 | -3.0% | earnings | Seeking Alpha | STRATA Skin Sciences, Inc. (SSKN) Q2 2025 Earnings Call Transcript |
| 2024-08-14 | +2.9% | earnings | Seeking Alpha | STRATA Skin Sciences GAAP EPS of -$0.03 beats by $0.67, revenue of $8.4M beats by $0.98M |
| 2024-08-14 | +2.9% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-05-11 | +2.6% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-02-14 | -2.6% | legal | SEC EDGAR | SSKN 8-K: 5.02 and (SEC Filing) |
| 2025-08-12 | -2.5% | earnings | Yahoo Finance | Strata Skin Sciences Inc (SSKN) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance |
| 2022-01-10 | +2.1% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-01-10 | +2.1% | legal | SEC EDGAR | SSKN 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2022-11-09 | -2.1% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01 (SEC Filing) |
| 2021-10-18 | -2.1% | legal | SEC EDGAR | SSKN 8-K: 1.01 and (SEC Filing) |
| 2025-08-16 | -1.6% | earnings | Yahoo Finance | Analysts Just Made A Major Revision To Their STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Revenue Forecasts - Yahoo Finance |
| 2025-12-23 | -1.6% | news | Trefis | Can Strata Skin Sciences Stock Recover If Markets Fall? - Trefis |
| 2024-11-13 | +1.6% | earnings | Seeking Alpha | STRATA Skin Sciences GAAP EPS of -$0.53 misses by $0.09, revenue of $8.8M beats by $0.26M |
| 2024-11-13 | +1.6% | legal | SEC EDGAR | SSKN 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2025-03-28 | -1.2% | earnings | Seeking Alpha | STRATA Skin Sciences, Inc. (SSKN) Q4 2024 Earnings Call Transcript |
| 2022-08-10 | -1.2% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-10-18 | +1.1% | news | simplywall.st | STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Surges 36% Yet Its Low P/S Is No Reason For Excitement - simplywall.st |
| 2024-05-15 | -1.0% | earnings | Seeking Alpha | STRATA Skin Sciences GAAP EPS of -$0.10 misses by $0.03, revenue of $6.75M misses by $0.16M |
| 2024-05-15 | -1.0% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01 (SEC Filing) |
| 2021-10-04 | +0.8% | legal | SEC EDGAR | SSKN 8-K: 1.01, 1.02, 2.03, 3.02, 5.02 (SEC Filing) |
| 2023-05-15 | -0.6% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-02-19 | -0.5% | news | GlobeNewswire | STRATA Skin Sciences Confirms Nasdaq Delisting |
| 2026-02-19 | -0.5% | news | Seeking Alpha | STRATA Skin Sciences files to delist, plans to go dark |
| 2026-02-19 | -0.5% | news | Yahoo Finance | STRATA Skin Sciences Confirms Nasdaq Delisting - Yahoo Finance |
| 2026-02-19 | -0.5% | news | Stock Titan | Dermatology device maker STRATA Skin exits Nasdaq to cut costs - Stock Titan |
| 2025-08-13 | -0.4% | earnings | Seeking Alpha | STRATA Skin Sciences GAAP EPS of -$0.60 misses by $0.31, revenue of $7.66M misses by $0.9M |
| 2025-08-13 | -0.4% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01 (SEC Filing) |
| 2021-05-12 | +0.3% | legal | SEC EDGAR | SSKN 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-02-21 | -0.2% | legal | SEC EDGAR | SSKN 8-K: 1.01, 2.03 (SEC Filing) |
| 2021-10-28 | -0.1% | legal | SEC EDGAR | SSKN 8-K: 5.02 (SEC Filing) |
| 2026-04-24 | — | news | MSN | STRATA Skin Sciences Shares Drop Following $2.42 Million Share Offering Announcement - MSN |